These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17641611)

  • 1. [Antioxidant and metabolic therapy of lower limb chronic obliterative arterial disease].
    Koshkin VM; Murav'ev SV; Dadova LV; Kalashov PB
    Angiol Sosud Khir; 2006; 12(3):29-32. PubMed ID: 17641611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of pentoxifylline and of bio-electromagnetic therapy in lower limb obliterative arterial disease].
    Bernát SI
    Orv Hetil; 2013 Oct; 154(42):1674-9. PubMed ID: 24121220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Conservative treatment of lower limb chronic obliterative atherosclerosis: strategy and tactics].
    Koshkin VM; Stoĭko IuM
    Angiol Sosud Khir; 2005; 11(1):132-5. PubMed ID: 16034335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
    Duthois S; Cailleux N; Lévesque H
    J Mal Vasc; 2000 Feb; 25(1):17-26. PubMed ID: 10705132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypervolemic treatment of the chronic obliterative arteriopathies of extremities.
    Brassai Z; Koválszki P; Pop GH; Kiss K; Olosz E
    Med Interne; 1986; 24(1):37-41. PubMed ID: 2422732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current state-of-the-art of rehabilitative treatment of chronic obliterative arterial diseases of the lower extremities].
    Badtieva VA; Kniazeva TA; Otto MP; Zueva EB
    Vopr Kurortol Fizioter Lech Fiz Kult; 2009; (6):53-6. PubMed ID: 20017386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are vasodilators indicated in the treatment of obliterative arteriopathy of the lower limbs?].
    Cuypers Y; Baudinet V; Collignon P; Joris H; Kulbertus H; Rutten F
    Rev Med Liege; 1966 Apr; 21(8):185-8. PubMed ID: 5932052
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of mild gravitational overload on the progression of lower limb arteriosclerosis obliterans].
    Makarov IV
    Angiol Sosud Khir; 2003; 9(4):31-5. PubMed ID: 14657908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of vasoprostan in the treatment of obliterating atherosclerosis of the lower limbs].
    Sukharev II; Guch AA
    Klin Khir (1962); 1994; (7):22-4. PubMed ID: 7823491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of gravitation overloading in the treatment of obliterative atherosclerosis of lower extremity arteries].
    Galkin RA; Kotel'nikov GP; Makarov IV; Oparin AN
    Vestn Khir Im I I Grek; 2003; 162(1):82-5. PubMed ID: 12708401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of drug-free methods of treatment in comprehensive therapy of patients with stage II chronic lower limb ischaemia].
    Makarov IV; Lukashova AV
    Angiol Sosud Khir; 2016; 22(2):21-6. PubMed ID: 27336329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic angiogenesis in treatment of patients with chronic obliterating diseases of lower limb arteries].
    Cherviakov IuV; Staroverov IN; Nersesian EG; Isaev AA; Deev RV
    Angiol Sosud Khir; 2012; 18(3):19-27. PubMed ID: 23059603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surheme in chronic obliterative arteriopathies of the lower limbs].
    Desruelles J; Waucampt JJ
    Lille Med; 1971 Jan; 16():Suppl 1:224-9. PubMed ID: 5162043
    [No Abstract]   [Full Text] [Related]  

  • 14. The significance of vasodilator therapy in obliterative arterial disease.
    Thulesius O
    Scand J Clin Lab Invest Suppl; 1967; 99():222-4. PubMed ID: 6056925
    [No Abstract]   [Full Text] [Related]  

  • 15. [Further trials of a long-acting vasodilator agent in 397 patients with cronic peripheral obliterating arteriopathy of a sclerotic nature].
    Ghezzi P; Cavaliere P; Berti Riboli E
    Minerva Cardioangiol; 1969 May; 17(5):333-6. PubMed ID: 5785731
    [No Abstract]   [Full Text] [Related]  

  • 16. [Endovascular correction of a multi-level arterial lesion in an elderly patient with lower-limb critical ischaemia].
    Ol'shanskiĭ MS; Esipenko VV; Ivanov AA; Moshurov IP; Kazanskiĭ DV
    Angiol Sosud Khir; 2007; 13(2):42-4. PubMed ID: 18004258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preoperative care of microcirculatory vessels in patients with lower limb arteriosclerosis obliterans].
    Kuznetsov MR; Koshkin VM; Karalkin AV; Boldin BV; Rodionov SV; Sergeeva NA; Petukhov EB; Golosnitskiĭ PIu
    Angiol Sosud Khir; 2005; 11(1):19-24. PubMed ID: 16034319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical trial of a long-acting vasodilator agent in chronic peripheral obliterating arteriopathy of a sclerotic nature].
    Gemma GB; Ghezzi P; Cavaliere P
    Minerva Cardioangiol; 1969 May; 17(5):324-32. PubMed ID: 5785730
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intra-arterial infusion in treatment of obliterating atherosclerosis of the lower extremities].
    Lutsenko SM; Pisarenko AS
    Klin Khir (1962); 1977 Sep; (9):63-6. PubMed ID: 916516
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemodynamics and principles of therapy of patients with obliterative atherosclerosis].
    Zavgorodniĭ LG; Taranenko LD
    Klin Khir (1962); 1969 Sep; 9():51-5. PubMed ID: 5402966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.